Shareholding disclosure

Newron Pharmaceuticals S.p.A.

Collectively declared rate

24.19%

Threshold

Crossed upwards

Timeline

Published

07.05.2014

Transaction

29.04.2014

Voting rights breakdown

Voting rights acquired24.19%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBE4B00049

Beneficial owner

GEFIM SPA

Declared address

GEFIM SPA, 20122 - Milan

Acquisition by Duba of 145'772 shares in Newron as part of an issue of 1'183'597 new shares in Newron which results in the aggregate number of shares and voting rights held by the group to decrease form 25.38% to 24.19% As of the date of this notice, the Newron shares are held dlrectly by Zambon and Duba Zambon Company S.p.A. Via Lillo del Duca n. 10,20091 - Bresso (Milan), Italy, Registry of Companies of Milan n. 01690280159 ("Zambon") is an entity controlled at 85.92% by GEFIM. DUBA A.B., Arsenalsgatan, No.8 C, 10332, Stockholm, Sweden ("DUBA") is a wholly-owned subsidiary of Investor. On 21 Jan 2013 Zambon and Duba entered into a shareholders agreement relating to their respective stakes in NEwron

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open